Immersive Virtual Reality for Pain-related Movement Dysfunctions in Patients With Chronic Shoulder Pain
Launched by UNIVERSITY OF MALAGA · Nov 28, 2022
Trial Information
Current as of January 14, 2025
Unknown status
Keywords
ClinConnect Summary
Studio Design Randomized controlled clinical trial (RCT). This protocol follows the indications of the guidelines for Clinical Trial Publications (CONSORT) and will follow the TIDIER check-list for the exhaustive description of the interventions that will be performed.
Target population Patients with persistent musculoskeletal shoulder pain aged 18-65 years primary chronic musculoskeletal pain, according to the International Classification of Diseases-11 (2019) of the International Association for the Study of Shoulder-related Pain (IASP).
Sample size calculation A total of 30 individuals...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • People from 18 to 65 years old
- • Shoulder pain of at least three months of evolution located in the proximal anterolateral region of the shoulder
- • Presenting shoulder pain during movements with a history of traumatic or insidious onset
- • Agree to participate in the study and sign the informed consent
- Exclusion Criteria:
- • Shoulder pain resulting from cervical spine dysfunction
- • Cognitive deficits
- • Uso of medications for pain control in the previous 24 hours
- • A history of neurological or psychiatric disorders
- • Adhesive capsulitis syndrome (limited passive range of motion of the shoulder: external rotation \< 30°; elevation \< 150°)
- • Patients with shoulder instability
- • Previous surgery of the shoulder
About University Of Malaga
The University of Malaga, a leading academic institution in Spain, is committed to advancing medical research and improving patient outcomes through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise in various fields, including medicine, health sciences, and biotechnology, to conduct rigorous studies. The institution is dedicated to fostering a culture of ethical research practices and ensuring the highest standards of safety and efficacy in its clinical trials, ultimately contributing to the development of groundbreaking therapies and enhancing the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Málaga, , Spain
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials